Botox study targets wrinkles in japan – phase 3 complete
NCT ID NCT06794866
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested Botox (onabotulinumtoxinA) in 150 Japanese adults with moderate to severe forehead lines. Participants received injections of either Botox or a placebo and were followed for up to 12 months. The goal was to see if Botox safely reduces wrinkle severity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
OnabotulinumtoxinA (Botox)
What this could lead to
If it works, this could provide a safe and effective option for reducing forehead wrinkles in Japanese adults.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. Placebo group means some may not benefit, and side effects like bruising or temporary muscle weakness are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOREHEAD LINES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akihabara Skin Clinic /ID# 268441
Tokyo, 101-0021, Japan
-
Chiharu Dermatology Clinic Urawa /ID# 268497
Saitama, 333-0055, Japan
-
Forest Palace Dermatology Clinic /ID# 268599
Nerima-ku, Tokyo, 177-0041, Japan
-
Ginza Skin Clinic /ID# 268532
Chuo-ku, Tokyo, 104-0061, Japan
-
Greenwood Skin Clinic Tachikawa /ID# 268528
Tachikawa-shi, Tokyo, 190-0023, Japan
-
Hiroshima Station Clinic /ID# 268467
Hiroshima, Hiroshima, 732-0053, Japan
-
Jun Clinic /ID# 268531
Nagano, Nagano, 380-0826, Japan
-
Kitasato University Kitasato Institute Hospital /ID# 268499
Minato-ku, Tokyo, 108-8642, Japan
-
Kotoni Tower Skin And Cosmetic Surgery Clinic /ID# 268460
Sapporo, Hokkaido, 063-0812, Japan
-
Queens Square Medical Center, Dermatology and Allergology /ID# 268454
Yokohama, Kanagawa, 220-6208, Japan
-
Tokai University Hospital /ID# 268496
Isehara, Kanagawa, 259-1193, Japan
-
Tokyo Asbo Clinic /ID# 268529
Chuo-ku, Tokyo, 104-0031, Japan
-
Tokyo Center Clinic /ID# 268477
Chuo-ku, Tokyo, 103-0027, Japan
-
Touyama Plastic Surgery Clinic /ID# 268456
Naha, Okinawa, 900-0015, Japan
-
Yoshikawa Skin Clinic /ID# 268494
Takatsuki, Osaka, 569-0824, Japan